-
Bisgaard Strong posted an update 1 year, 6 months ago
g., by repairing SOD1 mutations or the SMN2 splicing defect or deleting C9orf72 expanded repeats. These studies have shown promising results to approach therapeutic trials that should significantly lower the progression of these deadly disorders.A self-transcribing and replicating RNA (STARR)-based vaccine (LUNAR-COV19) has been developed to…[Read more]
-
Bisgaard Strong posted an update 1 year, 7 months ago
Among “extra-criteria” antiphospholipid antibodies (aPL), anti-phosphatidylserine/prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when investigating patients suspected of having antiphospholipid syndrome (APS). aPL detection is currently performed by solid-phase assays to identify anti-cardiolipin (aCL),…[Read more]
-
Bisgaard Strong posted an update 1 year, 7 months ago
This study aimed to explore the in vitro and in vivo roles of macrophages in the osteogenesis stimulated by BMP2-CPC. In vitro, the alteration of macrophage polarization and cytokine secretion induced by BMP2-CPC or CPC was investigated. The influence of conditioned medium derived from BMP2-CPC- or CPC-stimulated macrophages on the migration and…[Read more]
-
Bisgaard Strong became a registered member 1 year, 7 months ago

